| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |